These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 26374508)

  • 1. A basic overview of multiple sclerosis immunopathology.
    Grigoriadis N; van Pesch V;
    Eur J Neurol; 2015 Oct; 22 Suppl 2():3-13. PubMed ID: 26374508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
    Kutzelnigg A; Lassmann H
    Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications.
    Bennett JL; Stüve O
    Clin Neuropharmacol; 2009; 32(3):121-32. PubMed ID: 19483479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis.
    Kunkl M; Amormino C; Tedeschi V; Fiorillo MT; Tuosto L
    Front Immunol; 2022; 13():824411. PubMed ID: 35211120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis.
    Kunkl M; Frascolla S; Amormino C; Volpe E; Tuosto L
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of viral and self-antigens by T
    Paroni M; Maltese V; De Simone M; Ranzani V; Larghi P; Fenoglio C; Pietroboni AM; De Riz MA; Crosti MC; Maglie S; Moro M; Caprioli F; Rossi R; Rossetti G; Galimberti D; Pagani M; Scarpini E; Abrignani S; Geginat J
    J Allergy Clin Immunol; 2017 Sep; 140(3):797-808. PubMed ID: 28237728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pathogenic role of inflammation in multiple sclerosis].
    Martino G; Furlan R; Poliani PL
    Rev Neurol; 2000 Jun 16-30; 30(12):1213-7. PubMed ID: 10935253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in understanding the pathophysiology of multiple sclerosis.
    Zéphir H
    Rev Neurol (Paris); 2018 Jun; 174(6):358-363. PubMed ID: 29680179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
    Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
    Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages and neurodegeneration.
    Hendriks JJ; Teunissen CE; de Vries HE; Dijkstra CD
    Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic System and Neuroinflammation: Implication in Multiple Sclerosis.
    Di Bari M; Di Pinto G; Reale M; Mengod G; Tata AM
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):109-115. PubMed ID: 27550615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathology of multiple sclerosis.
    Fox EJ
    Neurology; 2004 Dec; 63(12 Suppl 6):S3-7. PubMed ID: 15623668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial.
    Sy M; Newton BL; Pawling J; Hayama KL; Cordon A; Yu Z; Kuhle J; Dennis JW; Brandt AU; Demetriou M
    J Neuroinflammation; 2023 Sep; 20(1):209. PubMed ID: 37705084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, demyelination, and degeneration - recent insights from MS pathology.
    Stadelmann C; Wegner C; Brück W
    Biochim Biophys Acta; 2011 Feb; 1812(2):275-82. PubMed ID: 20637864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.